Jeffrey Ronn
Pulmonary Disease · Surprise, AZNPI 1922097773
Payments from drug & device makers
Across 375 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Boehringer Ingelheim$998
- AstraZeneca$586
- Actelion Pharmaceuticals US, Inc.$556
- Harmony Biosciences LLC$361
- Genentech USA, Inc.$356
- plus $3K from 34 others
What the payments were for
- Food & beverage$7,258100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 71 | $1,155 |
| Boehringer Ingelheim | 43 | $998 |
| AstraZeneca | 29 | $586 |
| Actelion Pharmaceuticals US, Inc. | 26 | $556 |
| Harmony Biosciences LLC | 13 | $361 |
| Genentech USA, Inc. | 22 | $356 |
| Advanced Respiratory, Inc | 17 | $332 |
| Mylan Specialty L.p. | 18 | $326 |
| Philips North America LLC | 14 | $292 |
| Electromed, Inc. | 16 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $209 |
| Regeneron Healthcare Solutions, Inc. | 9 | $177 |
| Sanofi | 9 | $177 |
| Pulmonx Corporation | 7 | $176 |
| Boston Scientific | 3 | $108 |
| Novartis | 6 | $99 |
| Mallinckrodt Hospital Products Inc. | 5 | $95 |
| Abbott | 5 | $90 |
| Grifols USA, LLC | 2 | $89 |
| AbbVie(2 entities) | 5 | $83 |
| Sunovion Pharmaceuticals Inc. | 5 | $79 |
| Insmed, Inc. | 4 | $77 |
| Shire North American Group Inc | 4 | $77 |
| Amarin Pharma, Inc. | 4 | $70 |
| Gilead | 3 | $55 |
| Amgen | 3 | $52 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Circassia Inc. | 3 | $43 |
| Mayne Pharma Commercial LLC | 3 | $39 |
| UCB, Inc. | 3 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Merck | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $16 |
| Pfizer | 1 | $15 |
| Medtronic | 1 | $14 |
| Apria Healthcare LLC | 1 | $13 |
| Optos, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,258 in reported general payments places this provider in the 65th percentile of 250 pulmonary disease providers in Arizona.
Other pulmonary disease in Surprise
- Raj MulpuriSurprise$14K
- Khaleel SalahudeenSurprise$12K
- Muhammad SalimChandler$5.9M
- Vikas SayalBullhead City$3.7M
- David BaratzPhoenix$2.2M
- James RossPhoenix$2M
- Rajat WaliaPhoenix$1.9M
- Robert OrrPeoria$1.6M
- Sachin ChaudharyTucson$1.2M
- Mark GotfriedPhoenix$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.